Relapse

Advances in Parasitology

Volumn 80, Issue , 2012, Pages 113-150

  White, Nicholas J ^a   Imwong, Mallika ^a  

^a MAHIDOL UNIVERSITY   (Thailand)

Author keywords

Hypnozoites; Malaria; Plasmodium vivax; Relapse

Indexed keywords

8 AMINOQUINOLINE DERIVATIVE; ANTIMALARIAL AGENT; ARTEMETHER PLUS BENFLUMETOL; ARTESUNATE; CHLOROQUINE; ISOPENTAQUINE; MEPACRINE; PENTAQUINE; PLASMOQUINE; PRIMAQUINE; QUININE; UNCLASSIFIED DRUG;

AGE; ARTICLE; DISEASE TRANSMISSION; DRUG EFFECT; DRUG ELIMINATION; DRUG HALF LIFE; DRUG POTENTIATION; ENDEMIC DISEASE; GENETIC VARIABILITY; GENOTYPE; GEOGRAPHIC DISTRIBUTION; HUMAN; IMMUNE RESPONSE; IMMUNITY; MALARIA FALCIPARUM; NEUROSYPHILIS; PARASITEMIA; PERIODICITY; PHENOTYPE; PLASMODIUM FALCIPARUM; PLASMODIUM VIVAX; PLASMODIUM VIVAX MALARIA; PRIORITY JOURNAL; RECURRENT DISEASE; SPOROZOITE;

EID: 84870376266     PISSN: 0065308X     EISSN: None     Source Type: Book Series    
DOI: 10.1016/B978-0-12-397900-1.00002-5     Document Type: Chapter

References (126)

1. Adak T., Sharma V.P., Orlov V.S. Studies on the Plasmodium vivax relapse pattern in Delhi, India. Am. J. Trop. Med. Hyg. 1998, 59:175-179.
2. Adak T., Valecha N., Sharma V.P. Plasmodium vivax polymorphism in a clinical drug trial. Clin. Diagn. Lab. Immunol. 2001, 8:891-894.
3. Alving A.S., Craige B., Jones R., Whorton C.M., Pullman T.N., Eichelberger L. Pentaquine (SN-13,276) a therapeutic agent effective in reducing the relapse rate in vivax malaria. J. Clin. Invest. 1948, 27:25-33.
4. Alving A.S., Arnold J., Hockwald R.S., Clayman C.B., Dern R.J., Beutler E., Flanagan C.L. Potentiation of the curative action of primaquine in vivax malaria by quinine and chloroquine. J. Lab. Clin. Med. 1955, 46:301-306.
5. Arnold J., Alving A.S., Clayman C.B. Induced primaquine resistance in vivax malaria. Trans. R. Soc. Trop. Med. Hyg. 1961, 55:345-350.
6. Baird J.K. Resistance to therapies for infection by Plasmodium vivax. Clin. Microbiol. Rev. 2009, 22:508-534.
7. Beier J.C., Davis J.R., Vaughan J.A., Noden B.H., Beier M.S. Quantitation of Plasmodium falciparum sporozoites transmitted in vitro by experimentally infected Anopheles gambiae and Anopheles stephensi. Am. J. Trop. Med. Hyg. 1991, 44:564-570.
8. Bianco A.A., Saunders G.M., Levine A.S., Cohn R.V. Long term observation of Plasmodium vivax malaria. U. S. Naval Med. Bull. 1947, 47:550.
9. Bignami A. Concerning the pathogenesis of relapses in malarial fevers. South. Med. J. 1913, 6:79-89.
10. Boyd M.F. On strains or races of the malaria parasites. Am. J. Trop. Med. 1940, 20:69-80.
11. Boyd M.F. The influence of sporozoite dosage in vivax malaria. Am. J. Trop. Med. 1940, 20:279-286.
12. Boyd M.F. A review of studies on immunity to vivax malaria. J. Natl. Malar. Soc. 1947, 6:12-31.
13. Boyd M.F., Kitchen S.F. Renewed clinical activity in vivax malaria. Am. J. Trop. Med. Hyg. 1943, 23:221-234.
14. Boyd M.F., Stratman-Thomas W.K. A controlled technique for the employment of naturally induced malaria in the therapy of paresis. Am. J. Hyg. 1933, 17:37-43.
15. Boyd M.F., Stratman-Thomas W.K., Kitchen S.F. On the duration of homologous immunity to Plasmodium vivax. Am. J. Trop. Med. 1936, 21:s1-s16. 311-315.
16. Brasil P., de Pina Costa A., Saraiva Pedro R., da Silveira Bressan C., da Silva S., Tauil P.L., Daniel-Ribeiro C.T. Unexpectedly long incubation period of Plasmodium vivax malaria, in the absence of chemoprophylaxis, in patients diagnosed outside the transmission area in Brazil. Malar. J. 2011, 10:122.
17. Bray R.S., Garnham P.C. The life-cycle of primate malaria parasites. Br. Med. Bull. 1982, 38:117-122.
18. Chen N., Auliff A., Rieckmann K., Gatton M., Cheng Q. Relapses of Plasmodium vivax infection result from clonal hypnozoites activated at predetermined intervals. J. Infect. Dis. 2007, 195:934-941.
19. Coatney G.R., Cooper W.C., Ruhe D.S., Young M.D., Burgess R.W. Studies in human malaria. XVIII. The life pattern of sporozoite-induced St. Elizabeth strain vivax malaria. Am. J. Hyg. 1950, 51:200-215.
20. Coatney G.R., Cooper W.C., Young M.D. Studies in human malaria. XXX. A summary of 204 sporozoite-induced infections with the Chesson strain of Plasmodium vivax. J. Natl. Malar. Soc. 1950, 9:381-396.
21. Coatney G.R., Alving A.S., Jones R., Hankey D.D., Robinson D.H., Garrison P.L., Coker W.G., Donovan W.N., Di Lorenzo A., Marx R.L., Simmons I.H. Korean vivax malaria. V. Cure of the infection by primaquine administered during long-term latency. Am. J. Trop. Med. Hyg. 1953, 2:985-988.
22. Cogswell F.B. The hypnozoite and relapse in primate malaria. Clin. Microbiol. Rev. 1992, 5:26-35.
23. Collins W.E., Jeffery G.M. Primaquine resistance in Plasmodium vivax. Am. J. Trop. Med. Hyg. 1996, 55:243-249.
24. Cooper W.C., Coatney G.R., Ruhe D.S. Studies in human malaria. V. Homologous strain superinfection during latency in subjects with sporozoite-induced vivax malaria (St. Elizabeth strain). Am. J. Hyg. 1947, 46:141-148.
25. Cooper W.C., Ruhe D.S., Coatney G.R. Studies in human malaria. XVI. Results of massive sub-inoculation during latency from patients infected with St. Elizabeth strain vivax malaria. Am. J. Trop. Med. Hyg. 1949, 50:189-193.
26. Cooper W.C., Myatt A.V., Hernandez T., Jeffery G.M., Coatney G.R. Studies in human malaria. XXXI. Comparison of primaquine, isopentaquine, SN-3883, and pamaquine as curative agents against Chesson strain vivax malaria. Am. J. Trop. Med. Hyg. 1953, 2:949-957.
27. Craige B., Alving A.S., Jones R., Whorton C.M., Pullman T.N., Eichelberger L. The Chesson strain of Plasmodium vivax malaria. I. Relationship between prepatent period, latent period and relapse rate. J. Infect. Dis. 1947, 80:228-236.
28. Dembele L., Gego A., Zeeman A.M., Franetich J.F., Silvie O., Rametti A., Le Grand R., Dereuddre-Bosquet N., Sauerwein R., van Gemert G.J., Vaillant J.C., Thomas A.W., Snounou G., Kocken C.H., Mazier D. Towards an in vitro model of Plasmodiumhypnozoites suitable for drug discovery. PLoS One 2011, 6:e18162.
29. Di Lorenzo A., Marx R.L., Alving A.S., Jones R. Korean vivax malaria. IV. Curative effect of 15 milligrams of primaquine daily for 7 days. Am. J. Trop. Med. Hyg. 1953, 2:983-984.
30. Douglas N.M., Nosten F., Ashley E.A., Phaiphun L., van Vugt M., Singhasivanon P., White N.J., Price R.N. Plasmodium vivax recurrence following falciparum and mixed species malaria: risk factors and effect of anti-malarial kinetics. Clin. Infect. Dis. 2011, 52:612-620.
31. Ebisawa I. Malaria in China and the Equatorial Pacific Area from 1937 to 1943. Yale J. Biol. Med. 1973, 46:94-101.
32. Edgcomb J.H., Arnold J., Yount E.H., Alving A.S., Eichelberger L., Jeffery G., Eyles D., Young M.D. Primaquine, SN 13272, a new curative agent in vivax malaria; a preliminary report. J. Natl. Malar. Soc. 1950, 9:285-292.
33. Eichenlaub D., Reimann E., Bunjes R. Malaria tertiana bei Kindern und Erwachsenen aus dem Epidemiegebiet der südlichen Türkei. Dtsch. Med. Wschr. 1979, 104:288-292.
34. Eyles D.E., Young M.D. Studies on imported malarias the parasitological pattern of relapsing Plasmodium vivax in military patients. J. Natl. Mal Soc. 1948, 7:23-37.
35. Findlay G.M. Recent Advances in Chemotherapy. Malaria 1951, vol. 2. The Blakiston Company, Philadelphia. third ed.
36. Garnham P.C.C. Exoerythrocytic schizogony in Plasmodium kochi Laveran. A preliminary note. Trans. R. Soc. Trop. Med. Hyg. 1947, 40:719-722.
37. Garnham P.C.C. Malaria Parasites and Other Haemosporidiae 1966, Blackwell, Oxford.
38. Garnham P.C.C. Relapses and latency in malaria. Protozoology 1967, 2:55-64.
39. Garnham P.C. Swellengrebel lecture. Hypnozoites and 'relapses' in Plasmodium vivax and in vivax-like malaria. Trop. Geogr. Med. 1988, 40:187-195.
40. Gill C.A. The Seasonal Periodicity of Malaria and the Mechanism of the Epidemic Wave 1938, JA Churchill Ltd, London.
41. Gogtay N.J., Desai S., Kamtekar K.D., Kadam V.S., Dalvi S.S., Kshirsagar N.A. Efficacies of 5- and 14-day primaquine regimens in the prevention of relapses in Plasmodium vivax infections. Ann. Trop. Med. Parasitol. 1999, 93:809-812.
42. Gogtay N.J., Desai S., Kadam V.S., Kamtekar K.D., Dalvi S.S., Kshirsagar N.A. Relapse pattern of Plasmodium vivax in Mumbai: a study of 283 cases of vivax malaria. J. Assoc. Phys. India 2000, 48:1085-1086.
43. Goller J.L., Jolley D., Ringwald P., Biggs B.A. Regional differences in the response of Plasmodium vivax malaria to primaquine as anti-relapse therapy. Am. J. Trop. Med. Hyg. 2007, 76:203-207.
44. Hackett L.W. Malaria in Europe. An Ecological Study 1937, Oxford University Press, London.
45. Hanf M., Stéphani A., Basurko C., Nacher M., Carme B. Determination of the Plasmodium vivax relapse pattern in Camopi, French Guiana. Malar. J. 2009, 8:278.
46. Hankey D.D., Jones R., Coatney O.R., Alving A.S., Coker W.O., Garrison P.L., Donovan W.N. Korean vivax malaria. I. Natural history and response to chloroquine. Am. J. Trop. Med. Hyg. 1953, 2:958-969.
47. Hill E., Amatuzio D.S. Southwest Pacific vivax malaria; clinical features and observations concerning duration of clinical activity. Am. J. Trop. Med. Hyg. 1949, 29:203-214.
48. Höring R.O. Induced and war malaria. J. Trop. Med. Hyg. 1947, 50:150-159.
49. Howe C.D., Duff F.L. Effect of altitude anoxia in provoking relapse in malaria. Science 1946, 103:223.
50. Hulden L., Hulden L. Activation of the hypnozoite: a part of Plasmodium vivax life cycle and survival. Malar. J. 2011, 10:90.
51. Huldén L., Huldén L., Heliövaara K. Endemic malaria: an 'indoor' disease in northern Europe. Historical data analysed. Malar. J. 2005, 4:19.
52. Imwong M., Snounou G., Pukrittayakamee S., Tanomsing N., Kim J.R., Nandy A., Guthmann J.P., Nosten F., Carlton J., Looareesuwan S., Nair S., Sudimack D., Day N.P., Anderson T.J., White N.J. Relapses of Plasmodium vivax infection usually result from activation of heterologous hypnozoites. J. Infect. Dis. 2007, 195:927-933.
53. Imwong M., Nakeesathit S., Day N.P.J., White N.J. A review of mixed malaria species infections in anopheline mosquitoes. Malar. J. 2011, 10:253.
54. Imwong M., Boel M.E., Pagornrat W., Pimanpanarak M., McGready R., Day N.P., Nosten F., White N.J. The first Plasmodium vivax relapses of life are usually genetically homologous. J. Infect. Dis. 2012, 205:680-683.
55. James S.P. Some general results of a study of induced malaria in England. Trans. R Soc. Trop. Med. Hyg. 1931, 24:477-538.
56. James S.P. The use of plasmoquine in the prevention of malarial infections. Proc. R. Acad. Sci. Amsterdam 1931, 34:1424-1425.
57. James S.P., Shute P.G. Report on the First Results of Laboratory Work on Malaria in England. C. H. Malaria 1926, vol. 57. League of Nations. Health Organisation, Geneva, p. 30.
58. James S.P., Nicol W.D., Shute P.G. Clinical and parasitological observations on induced malaria. Proc. R. Soc. Med. 1936, 29:27-42.
59. Jeffery G.M. Relapses with Chesson strain Plasmodium vivax following treatment with chloroquine. Am. J. Trop. Med. Hyg. 1956, 5:1-13.
60. Jiang J.B., Huang J.C., Liang D.S., Liu J.X., Zhang S.W., Cheng F.C. Long incubation of Plasmodium vivax multinucleatum as demonstrated in three experimental human cases. Trans. R. Soc. Trop. Med. Hyg. 1982, 76:845-847.
61. Kim J.R., Nandy A., Maji A.K., Addy M., Dondorp A.M., Day N.P., Pukrittayakamee S., White N.J., Imwong M. Genotyping of Plasmodium vivax reveals both short and long latency relapse patterns in Kolkata. PLoS One 2012, 7:e39645.
62. Kopel E., Schwartz E., Amitai Z., Volovik I. Relapsing vivax malaria cluster in Eritrean refugees, Israel. Euro Surveill. 2010, 15:19601.
63. Korteweg P.C. Hereinneringsbundel voor Prof SS Rosenstein 1902, Leiden.
64. Krotoski W.A. Discovery of the hypnozoite and a new theory of malarial relapse. Trans. R. Soc. Trop. Med. Hyg. 1985, 79:1-11.
65. Krotoski W.A., Krotoski D.M., Garnham P.C.C., Bray R.S., Killick-Kendrick R., Draper C.C., Targett O.A.T., Guy M.W. Relapses in primate malaria: discovery of two populations of exoerythrocytic stages. Preliminary note. Brit. Med. J. 1980, 1:153-154.
66. Krotoski W.A., Collins W.E., Bray R.S., Garnham P.C.C., Cogswell F.B., Gwadz R.W., Killick-Kendrick R., Wolf R., Sinden R., Koontz L.C., Stanfill P.S. Demonstration of hypnozoites in sporozoite-transmitted Plasmodium vivax infection. Am. J. Trop. Med. Hyg. 1982, 31:1291-1293.
67. Krotoski W.A., Garnham P.C., Cogswell F.B., Collins W.E., Bray R.S., Gwasz R.W., Killick-Kendrick R., Wolf R.H., Sinden R., Hollingdale M., Lowrie R.C., Koontz L.C., Stanfill P.S. Observations on early and late post-sporozoite tissue stages in primate malaria. IV. Pre-erythrocytic schizonts and/or hypnozoites of Chesson and North Korean strains of Plasmodium vivax in the chimpanzee. Am. J. Trop. Med. Hyg. 1986, 35:263-274.
68. Levine H.D. Clinical aspects of malaria. Infectious Diseases 1963, vol. 2:479-492. Office of the Surgeon General, Department of the Army.
69. Looareesuwan S., White N.J., Chittamas S., Bunnag D., Harinasuta T. High rate of Plasmodium vivax relapse following treatment of falciparum malaria in Thailand. Lancet 1987, 2:1052-1055.
70. Luxemburger C., Thwai K.L., White N.J., Webster H.K., Kyle D.E., Maelankirri L., Chongsuphajaisiddhi T., Nosten F. The epidemiology of malaria in a Karen population on the western border of Thailand. Trans. R. Soc. Trop. Med. Hyg. 1996, 90:105-111.
71. Luxemburger C., van Vugt M., Jonathan S., McGready R., Looareesuwan S., White N.J., Nosten F. Treatment of vivax malaria in an endemic area on the western border of Thailand. Trans. R. Soc. Trop. Med. Hyg. 1999, 93:433-438.
72. Lysenko A.J., Beljaev A.E., Rybalka V.M. Population studies of Plasmodium vivax. 1. The theory of polymorphism of sporozoites and epidemiological phenomena of tertian malaria. Bull. World Health Organ. 1977, 55:541-549.
73. Mayxay M., Pukrittayakamee S., Newton P.N., White N.J. Mixed-species malaria infections in humans. Trends Parasitol. 2004, 20:233-240.
74. McLester J.B. Relapsing malaria. M Bull. Mediterranean Theat. 1945, 3:111-113.
75. Mendis K., Sina B.J., Marchesini P., Carter R. The neglected burden of Plasmodium vivax malaria. Am. J. Trop. Med. Hyg. 2001, 64(1-2 Suppl):97-106.
76. Moshkovsky S.D. Explanation for the difference of incubation type and features of alteration of acute periods of tertian malaria associated with different strains of Plasmodium vivax. Med. Parazitol. 1973, 42:393-400. (in Russian).
77. Most H. Clinical trials of anti-malarial drugs. Infectious Diseases 1963, vol. 2:525-598. Office of the Surgeon General, Department of the Army.
78. Mowrey F.H. Statistics of malaria. Infectious Diseases 1963, vol. 2:449-463. Office of the Surgeon General, Department of the Army.
79. MRC Malaria sub-committee Report on relapsing vivax malaria. MLE 1945, 30.
80. Nikolaiev B.P. Subspecies of the parasite of tertian malaria (Plasmodium vivax). Dokl. Akad. Navk. USSR 1949, 67:201-210.
81. Noe W.L., Green C.C., Cheney G. Natural course of Southwest Pacific malaria. Am. J. Med. Sci. 1946, 211:215-228.
82. Nosten F., Luxemburger C., Kyle D.E., Ballou W.R., Wittes J., Heh Wah, Chongsuphajaisiddhi T., Gordon D.M., White N.J., Sadoff J.C., Heppner D.G. Randomised double-blind placebo-controlled efficacy trial of the SPf66 vaccine against falciparum malaria in children in north-western Thailand. Lancet 1996, 348:701-707.
83. Ponnudurai T., Lensen A.H.W., van-Gemart G.J.A., Bolmer M.G., Meuwissen J.H. Feeding behaviour and sporozoite ejection by infected Anopheles stephensi. Trans. R. Soc. Trop. Med. Hyg. 1991, 85:175-180.
84. Prasad R.N., Virk K.J., Sharma V.P. Relapse/reinfection patterns of Plasmodium vivax infection: a four year study. Southeast. Asian J. Trop. Med. Public Health 1991, 22:499-503.
85. Pukrittayakamee S., Chantra A., Simpson J.A., Vanijanonta S., Clemens R., Looareesuwan S., White N.J. Therapeutic responses to different anti-malarial drugs in vivax malaria. Antimicrob. Agents Chemother. 2000, 44:1680-1685.
86. Pukrittayakamee S., Imwong M., Chotivanich K., Singhasivanon P., Day N.P., White N.J. A comparison of two short-course primaquine regimens for the treatment and radical cure of Plasmodium vivax malaria in Thailand. Am. J. Trop. Med. Hyg. 2010, 82:542-547.
87. Ratcliff A., Siswantoro H., Kenangalem E., Maristela R., Wuwung R.M., Laihad F., Ebsworth E.P., Anstey N.M., Tjitra E., Price R.N. Two fixed-dose artemisinin combinations for drug-resistant falciparum and vivax malaria in Papua, Indonesia: an open-label randomised comparison. Lancet 2007, 369:757-765.
88. Restrepo E., Imwong M., Rojas W., Carmona-Fonseca J., Maestre A. High genetic polymorphism of relapsing P. vivax isolates in northwest Colombia. Acta Trop. 2011, 119:23-29.
89. Robinson D.H., Di Lorenzo A., Marx R.L., Simmons I.H., Alving A.S., Hankey D.D., Coatney G.R., Jones R., Coker W.G., Garrison P.L., Donovan W.N. Korean vivax malaria. II. Curative treatment with pamaquine and primaquine. Am. J. Trop. Med. Hyg. 1953, 2:970-976.
90. Rosenburg R., Wirtz R.A. An estimation of the number of sporozoites ejected by a feeding mosquito. Trans. R. Soc. Trop. Med. Hyg. 1990, 84:209-212.
91. Ross R. An interim report on the treatment of malaria. Trans. R. Soc. Trop. Med. Hyg. 1918, 11:179-204.
92. Ruhe D.S., Cooper W.C., Coatney G.R., Josephson E.S. Studies in human malaria. XV. The therapeutic action of pamaquine against St. Elizabeth strain vivax malaria. Am. J. Hyg. 1949, 49:367-373.
93. Saifi M.A., Wajihullah, Siddiqui M.I., Al-Khalifa M.S. Malaria: patterns of relapse and resistance. J. King Saud Univ. (Science) 2010, 22:31-36.
94. Schmidt L.H. Compatibility of relapse patterns of Plasmodium cynomolgi infections in Rhesus monkeys with continuous cyclical development and hypnozoite concepts of relapse. Am. J. Trop. Med. Hyg. 1986, 35:1077-1099.
95. Schuffner W.A.C., Kortweg P.C., Swellengrebel N.H. Pathology - experimental malaria with protracted incubation. Proc. R. Acad. Sci. Amsterdam 1929, 32:903-911.
96. Shortt H.E., Garnham P.C.C. Pre-erythrocytic stage in mammalian malaria parasites. Nature 1948, 161:126.
97. Shortt H.E., Garnham P.C.C. Demonstration of a persisting exo-erythrocytic cycle in Plasmodium cynomolgi and its bearing on the production of relapses. Brit. Med. J. 1948, 1:1225-1228.
98. Shortt H.E., Garnham P.C.C. The pre-erythrocytic development of Plasmodium cynomolgi and Plasmodium vivax. Trans. R Soc. Trop. Med. Hyg. 1948, 41:785-795.
99. Shortt H.E., Garnham P.C.C., Covell G., Shute P.G. The pre-erythrocytic stage of human malaria, Plasmodium vivax. Brit. Med. J. 1948, 1:547.
100. Shortt H.E., Garnham P.C.C., Malamos B. The pre-erythrocytic stage of mammalian malaria. Brit. Med. J. 1948, 1:192-194.
101. Shute P.O. Latency and long-term relapses in benign tertian malaria. Trans. R Soc. Trop. Med. Hyg. 1946, 40:189-200.
102. Shute P.G., Garnham P.C.C., Maryon M. The Madagascar strain of Plasmodium vivax. Arch. Inst. Pasteur Madagascar 1978, 47:173-183.
103. Silachamroon U., Krudsood S., Treeprasertsuk S., Wilairatana P., Chalearmrult K., Mint H.Y., Maneekan P., White N.J., Gourdeuk V.R., Brittenham G.M., Looareesuwan S. Clinical trial of oral artesunate with or without high-dose primaquine for the treatment of vivax malaria in Thailand. Am. J. Trop. Med. Hyg. 2003, 69:14-18.
104. Singh N., Mishra A.K., Sharma V.P. Radical treatment of vivax malaria in Madhya Pradesh, India. Indian J. Malariol. 1990, 27:55-56.
105. Sinha S., Dua V.K., Sharma V.P. Malaria relapses and chloroquine resistance at the BHEL industrial complex, Hardwar, India. Trans. R. Soc. Trop. Med. Hyg. 1989, 83:606-610.
106. Sinton J.A. Studies on malaria with special reference to treatment. XV. Does the strain of parasite influence cure?. Indian J. Med. Res. 1931, 18:845-853.
107. Sinton J.A., Bird W. Studies in malaria with special reference to treatment; plasmoquine in treatment of malaria. Indian J. Med. Res. 1928, 16:159.
108. Sinton J.A., Smith S., Potinger D. Studies in malaria, with special reference to treatment. XII. Further researches into treatment of chronic benign tertian malaria with plasmoquine and quinine. Indian J. Med. Res. 1930, 17:793.
109. Smithuis F., Kyaw M.K., Phe O., Win T., Aung P.P., Oo A.P., Naing A.L., Nyo M.Y., Myint N.Z., Imwong M., Ashley E., Lee S.J., White N.J. Effectiveness of five artemisinin combination regimens with or without primaquine in uncomplicated falciparum malaria: an open-label randomised trial. Lancet Infect. Dis. 2010, 10:673-681.
110. Smoak B.L., DeFraites R.F., Magill A.J., Kain K.C., Wellde B.T. Plasmodium vivax infections in U.S. Army troops: failure of primaquine to prevent relapse in studies from Somalia. Am. J. Trop. Med. Hyg. 1997, 56:231-234.
111. Srivastava H.C., Sharma S.K., Bhatt R.M., Sharma V.P. Studies on Plasmodium vivax relapse pattern in Kheda district, Gujarat. Indian J. Malariol. 1996, 33:173-179.
112. Swellengrebel N.H., De Buck A. Malaria in the Netherlands 1938, Scheltema & Holkema, Amsterdam.
113. Swellengrebel N.H., De Buck A., Schoute E., Kraan M.H. Investigations on the transmission of malaria in some villages north of Amsterdam. Quart. Bull. Health Org. League Nations 1936, 3:295-352.
114. Tauil P.L., Luz F.C., Oliveira A.P., Deckers F.A., Santos J.B. Vivax malaria with long incubation period, detected in the Federal District: three case reports. Rev. Soc. Bras. Med. Trop 2010, 43:213-214.
115. Tiburskaja N.A., Sergiev P.O., Vrublevskaja O.S. Dates of onset of relapses and the duration of infection in induced tertian malaria with short and long incubation periods. Bull. World Health Organ. 1968, 38:447-457.
116. Tiburskaja N.A. Features specific to the Moscow strain of P. vivax. Medskayta Parazit-Moscow 1961, 30:446-454.
117. Ungureanu E., Killick-Kendrick R., Garnham P.C.C., Branzei P., Shute P.G. Pre-patent periods of a tropical strain of Plasmodium vivax after inoculations of tenfold dilutions of sporozoites. Trans. R. Soc. Trop. Med. Hyg. 1976, 70:482-483.
118. Walker E. The seasonal pattern of Plasmodium vivax malaria in Glasgow. J. Infect. 1983, 7:227-230.
119. Warwick R., Swimer G.J., Britt R.P. Prolonged incubation period of imported P. vivax malaria in London. J. R. Soc. Med. 1980, 73:333-336.
120. White N.J. Determinants of relapse periodicity in Plasmodium vivax malaria. Malar. J. 2011, 10. e 297.
121. Whorton C.M., Yount E., Jones R., Alving A.S., Pullman T.N., Craige B., Eichelberge L. The Chesson strain of Plasmodium vivax malaria; clinical aspects. J. Infect. Dis. 1947, 80:237-249.
122. Wilson T., Reid J.A. Malaria among prisoners of war in Siam (F Force). Trans. R. Soc. Trop. Med. Hyg. 1949, 43:257-272.
123. Winckel C.W.F. Are the experimental data of therapeutic malaria applicable to conditions obtaining in nature. Am. J. Trop. Med. Hyg. 1941, 789-794.
124. Winckel C.W.F. Long-latency in Plasmodium vivax infections in a temperate zone. Doc. Med. Geogr. Trop. 1955, 7:292-298.
125. Yorke W. Further observations on malaria made during the treatment of general paralysis. Trans. R. Soc. Trop. Med. Hyg. 1925, 19:108-122.
126. Yorke W., MacFie J.W.S. Observations on malaria made during the treatment of general paralysis. Trans. R. Soc. Trop. Med. Hyg. 1924, 18:13-37.